RecruitingPhase 2NCT02706704

Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
American University of Beirut Medical Center
Principal Investigator
Rola N Hamam, MD
American University of Beirut Medical Center
Intervention
Adalimumab(drug)
Enrollment
32 target
Eligibility
18 years · All sexes
Timeline
20162026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02706704 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials